Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes.
about
Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?New Antibiotics in Development Target Highly Resistant Gram-Negative Organisms.Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis: A Multicenter, Randomized, Double-Blind, Phase 2 Study.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Antibiotics, Resistome and Resistance Mechanisms: A Bacterial Perspective
P2860
Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plazomicin Activity against 34 ...... noglycoside-Modifying Enzymes.
@en
Plazomicin Activity against 34 ...... noglycoside-Modifying Enzymes.
@nl
type
label
Plazomicin Activity against 34 ...... noglycoside-Modifying Enzymes.
@en
Plazomicin Activity against 34 ...... noglycoside-Modifying Enzymes.
@nl
prefLabel
Plazomicin Activity against 34 ...... noglycoside-Modifying Enzymes.
@en
Plazomicin Activity against 34 ...... noglycoside-Modifying Enzymes.
@nl
P2093
P2860
P356
P1476
Plazomicin Activity against 34 ...... noglycoside-Modifying Enzymes.
@en
P2093
Carmen Rodríguez-Avial
Esther Culebras
Esther Rios
Iciar Rodríguez-Avial
José Manuel Viñuela-Prieto
Juan J Picazo
Maria Del Carmen López-Diaz
P2860
P356
10.1128/AAC.02454-16
P407
P577
2016-12-05T00:00:00Z